Companies Dominating the Cell Proliferation Kit Landscape
- Thermo Fisher Scientific, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Becton, Dickinson and Company
- General Electric Company
- PerkinElmer Inc.
- F. Hoffmann-La Roche AG
- Biotium, Inc.
- Mindray Medical International Limited
- Biological Industries
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of cell proliferation kit is evaluated at USD 746.76 million.
The cell proliferation kit market size was valued at USD 624.4 million in 2024 and is set to exceed USD 2.63 billion by 2037, expanding at over 11.7% CAGR during the forecast period i.e., between 2025-2037. Increasing rate of patients diagnosed with cancer & tumors, and the rising conscious towards healthcare will boost the market growth.
North America industry is expected to dominate majority revenue share by 2037, due to increasing frequency of new cancer cases such as melanoma, urothelial carcinoma, lung cancer, and others in the region.
The major players in the market are Thermo Fisher Scientific, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, General Electric Company, PerkinElmer Inc., F. Hoffmann-La Roche AG, Biotium, Inc., Mindray Medical International Limited, Biological Industries
